[Hemorrhagic cystitis caused by BK and JC polyomavirus in patients treated with bone marrow transplantation: clinical features and urologic management].
BACKGROUND
Differential diagnosis of hematuria after bone marrow transplantation (B.M.T.) may include polyomavirus (BK and JC)-associated haemorrhagic cystitis. Many reports have implied BK virus as the major pathogen in the development of hemorrhagic cystitis after BMT. BK viruria is also associated with ureteric stenosis in renal allografts recipients. Viral urinary tract infections are uncommon in healthy individuals, but we can find them frequently in patients under immunosuppressive conditions.


METHODS
Retrospective study of 123 consecutive B.M.T. recipients in the period from 1995 to 2000, evaluating those with polyomavirus-associated hemorrhagic cystitis. We present patient's characteristics, primary disease, clinical features, diagnosis aspects and treatment of these "hidden hosts of urinary tract".


RESULTS
7 patients (5.7% of B.M.T.) developed BK or JC virus-associated hemorrhagic cystitis; 3 men and 4 women; median patient age was 29 years (range 14 to 45 years). Bacterial, mycobacterial and parasitic urine cultivates had negative results in all of them. The clinical course was characterized by a late onset of haemorrhagic cystitis (days +30 to +132 after BMT). All 7 patients developed macroscopic haematuria (duration 3 to 30 days). In 6 cases Graft Versus Host Disease (G.V.H.D.) criteria were found. Ultrasonographic studies revealed diffuse thickening of bladder wall in 5 patients. Hematuria was managed by hyperhydratation, blood transfusions, transurethral catheter and evacuation of blood clots, continuous bladder irrigation, urine alkalinization and antiviral therapy. No other more aggressive measures were required to stop the bleeding. Only 1 case of transient elevated creatinine.


CONCLUSIONS
Polyomavirus-associated haemorrhagic cystitis must be considered in differential diagnosis of hematuria in bone marrow transplantation recipients. Urological management, according with the severity and duration of hematuria, is frequently required.
García Ligero
J
J
Servicio de Urología, Hospital General Universitario de Murcia.
Mora Peris
B
B
García García
F
F
Navas Pastor
J
J
Tomás Ros
M
M
Sempere Gutiérrez
A
A
Rico Galiano
J L
JL
Fontana Compiano
L O
LO
D000293:Adolescent; D000328:Adult; D001739:BK Virus; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003556:Cystitis / Q000821:virology*; D005260:Female; D006470:Hemorrhage / Q000821:virology; D006801:Humans; D007577:JC Virus; D008297:Male; D008875:Middle Aged; D027601:Polyomavirus Infections / Q000209:etiology*; D014412:Tumor Virus Infections / Q000209:etiology*